Skip to main content
Erschienen in: World Journal of Urology 1/2014

01.02.2014 | Original Article

Open versus laparoscopic partial nephrectomy for clinical T1a renal masses: a matched-pair comparison of 280 patients with TRIFECTA outcomes (RECORd Project)

verfasst von: Andrea Minervini, Giampaolo Siena, Alessandro Antonelli, Giampaolo Bianchi, Aldo Massimo Bocciardi, Sergio Cosciani Cunico, Vincenzo Ficarra, Cristian Fiori, Ferdinando Fusco, Andrea Mari, Giuseppe Martorana, Mauro Medica, Vincenzo Mirone, Giuseppe Morgia, Francesco Porpiglia, Francesco Rocco, Bruno Rovereto, Riccardo Schiavina, Claudio Simeone, Carlo Terrone, Alessandro Volpe, Marco Carini, Sergio Serni, and Members of the RECORd Project-LUNA Foundation

Erschienen in: World Journal of Urology | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Aim of the study

To report a matched-pair comparative analysis between open (OPN) and laparoscopic partial nephrectomy (LPN) for clinical (c) T1a renal masses from a large prospective multicenter dataset.

Materials and methods

The RECORd Project includes all patients who underwent OPN and LPN for kidney cancer between January 2009 and January 2011 at 19 Italian centers. Open and laparoscopic groups were compared regarding clinical, surgical, pathologic, functional results and TRIFECTA outcome. Multivariable logistic regression models were used to analyze predictors of WIT >25 min, surgical complications (SC) and the achievement of the TRIFECTA outcome.

Results

Overall, 301 patients had OPN and 149 LPN. Groups were matched 1:1 (140 matched pairs) for clinical diameter, tumor location and type of indication. Laparoscopic partial nephrectomy was associated with a significantly mean longer WIT (19.9 vs. 15.1 min; p < 0.001), and it was an independent predictor of a WIT >25 min (RR 6.29, p < 0.0001). The TRIFECTA was achieved in 78.6 and 74.3 % after OPN and LPN (p = ns), respectively, and the surgical approach was not a predictor of a negative TRIFECTA and SC at multivariable analysis. At 6-month follow-up, no significant differences were observed between the OPN and LPN group both in estimated glomerular filtration rate (eGFR) (∆GFR 1.1 vs. 4.1 mL/min) and in new-onset stage III–V chronic kidney disease (CKD) rate (0 vs. 0.7 %).

Conclusion

No significant difference in achieving the TRIFECTA outcome was reported after OPN and LPN. LPN was associated with a significantly longer WIT. However, eGFR at 6-month follow-up did not differ significantly between the two surgical approaches.
Literatur
1.
Zurück zum Zitat Kane CJ, Mallin K, Ritchey J et al (2008) Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer 113:78–83PubMedCrossRef Kane CJ, Mallin K, Ritchey J et al (2008) Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer 113:78–83PubMedCrossRef
2.
Zurück zum Zitat Ljungberg B, Cowan NC, Hanbury DC et al (2010) EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 58:398–406PubMedCrossRef Ljungberg B, Cowan NC, Hanbury DC et al (2010) EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 58:398–406PubMedCrossRef
3.
Zurück zum Zitat Minervini A, Ficarra V, Rocco F (2011) Simple enucleation is equivalent to traditional partial nephrectomy for renal cell carcinoma: results of a nonrandomized, retrospective, comparative study. J Urol 185:1604–1610PubMedCrossRef Minervini A, Ficarra V, Rocco F (2011) Simple enucleation is equivalent to traditional partial nephrectomy for renal cell carcinoma: results of a nonrandomized, retrospective, comparative study. J Urol 185:1604–1610PubMedCrossRef
4.
Zurück zum Zitat Minervini A, Serni S, Tuccio A et al (2012) Simple enucleation versus radical nephrectomy in the treatment of pT1a and pT1b renal cell carcinoma. Ann Surg Oncol 19(2):694–700PubMedCrossRef Minervini A, Serni S, Tuccio A et al (2012) Simple enucleation versus radical nephrectomy in the treatment of pT1a and pT1b renal cell carcinoma. Ann Surg Oncol 19(2):694–700PubMedCrossRef
5.
Zurück zum Zitat Porpiglia F, Volpe A, Billia M et al (2008) Laparoscopic versus open partial nephrectomy: analysis of the current literature. Eur Urol 53:732–743 discussion 742–3PubMedCrossRef Porpiglia F, Volpe A, Billia M et al (2008) Laparoscopic versus open partial nephrectomy: analysis of the current literature. Eur Urol 53:732–743 discussion 742–3PubMedCrossRef
6.
Zurück zum Zitat Marszalek M, Meixl H, Polajnar M et al (2009) Laparoscopic and open partial nephrectomy: a matched-pair comparison of 200 patients. Eur Urol 55:1171–1178PubMedCrossRef Marszalek M, Meixl H, Polajnar M et al (2009) Laparoscopic and open partial nephrectomy: a matched-pair comparison of 200 patients. Eur Urol 55:1171–1178PubMedCrossRef
7.
Zurück zum Zitat Gill IS, Kavoussi LR, Lane BR et al (2007) Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 178:41–46PubMedCrossRef Gill IS, Kavoussi LR, Lane BR et al (2007) Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 178:41–46PubMedCrossRef
8.
Zurück zum Zitat Khalifeh A, Autorino R, Hillyer Sp et al (2013) Comparative outcomes and assessment of Trifecta in 500 robotic and laparoscopic partialnephrectomy cases: a single surgeon experience. J Urol 189(4):1236–1242PubMedCrossRef Khalifeh A, Autorino R, Hillyer Sp et al (2013) Comparative outcomes and assessment of Trifecta in 500 robotic and laparoscopic partialnephrectomy cases: a single surgeon experience. J Urol 189(4):1236–1242PubMedCrossRef
9.
Zurück zum Zitat Hung AJ, Cai J, Simmons MN et al (2013) “Trifecta” in partial nephrectomy. J Urol 189(1):36–42PubMedCrossRef Hung AJ, Cai J, Simmons MN et al (2013) “Trifecta” in partial nephrectomy. J Urol 189(1):36–42PubMedCrossRef
10.
Zurück zum Zitat Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655PubMedCrossRef Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655PubMedCrossRef
11.
Zurück zum Zitat Patard JJ, Leray E, Cindolo L et al (2004) Multi-institutional validation of a symptom based classification for renal cell carcinoma. J Urol 172:858–862PubMedCrossRef Patard JJ, Leray E, Cindolo L et al (2004) Multi-institutional validation of a symptom based classification for renal cell carcinoma. J Urol 172:858–862PubMedCrossRef
12.
Zurück zum Zitat Greene FL, Page DL, Fleming ID et al (2002) American Joint Committee on Cancer (AJCC) Staging Manual, 6th edn. Springer, PhiladelphiaCrossRef Greene FL, Page DL, Fleming ID et al (2002) American Joint Committee on Cancer (AJCC) Staging Manual, 6th edn. Springer, PhiladelphiaCrossRef
13.
Zurück zum Zitat Kovacs G, Akhtar M, Beckwith BJ et al (1997) The Heidelberg classification of renal cell tumors. J Pathol 183:131–133PubMedCrossRef Kovacs G, Akhtar M, Beckwith BJ et al (1997) The Heidelberg classification of renal cell tumors. J Pathol 183:131–133PubMedCrossRef
14.
Zurück zum Zitat Fuhrman S, Lasky LC, Limas L (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655–663PubMedCrossRef Fuhrman S, Lasky LC, Limas L (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655–663PubMedCrossRef
15.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a color of 6,336 patients and result of a survey. Ann Surg 240:205–213PubMedCrossRef Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a color of 6,336 patients and result of a survey. Ann Surg 240:205–213PubMedCrossRef
16.
Zurück zum Zitat Rosenbaum PR, Rubin DB (1983) The central role of the propensity score in observational studies for causal effects. Biometrika 70(1):41–55CrossRef Rosenbaum PR, Rubin DB (1983) The central role of the propensity score in observational studies for causal effects. Biometrika 70(1):41–55CrossRef
17.
Zurück zum Zitat Jasjeet S. Sekhon. Multivariate and propensity score matching software with automated balance optimization: the matching package for R J Stat Soft 42:7 (2011/5) Jasjeet S. Sekhon. Multivariate and propensity score matching software with automated balance optimization: the matching package for R J Stat Soft 42:7 (2011/5)
18.
Zurück zum Zitat Lane BR, Campbell SC, Gill IS (2013) 10-year oncological outcomes after laparoscopic and open partial nephrectomy. J Urol pii: S0022-5347(13)00004-9 Lane BR, Campbell SC, Gill IS (2013) 10-year oncological outcomes after laparoscopic and open partial nephrectomy. J Urol pii: S0022-5347(13)00004-9
19.
Zurück zum Zitat Springer C, Hoda MR, Fajkovic H et al (2013) Laparoscopic vs open partial nephrectomy for T1 renal tumours: evaluation of long-term oncological and functional outcomes in 340 patients. BJU Int 111(2):281–288PubMedCrossRef Springer C, Hoda MR, Fajkovic H et al (2013) Laparoscopic vs open partial nephrectomy for T1 renal tumours: evaluation of long-term oncological and functional outcomes in 340 patients. BJU Int 111(2):281–288PubMedCrossRef
20.
Zurück zum Zitat Thompson RH, Lane BR, Lohse CM et al (2012) Renal function after partial nephrectomy: effect of warm ischemia relative to quantity and quality of preserved kidney. Urology 79(2):356–360PubMedCrossRef Thompson RH, Lane BR, Lohse CM et al (2012) Renal function after partial nephrectomy: effect of warm ischemia relative to quantity and quality of preserved kidney. Urology 79(2):356–360PubMedCrossRef
21.
Zurück zum Zitat Thompson RH, Lane BR, Lohse C et al (2010) Every minute counts when the renal hilum is clamped during partial nephrectomy. Eur Urol 58(3):340–345PubMedCrossRef Thompson RH, Lane BR, Lohse C et al (2010) Every minute counts when the renal hilum is clamped during partial nephrectomy. Eur Urol 58(3):340–345PubMedCrossRef
22.
Zurück zum Zitat Nguyen MM, Gill IS (2008) Halving ischemia time during laparoscopic partial nephrectomy. J Urol 179:627–632PubMedCrossRef Nguyen MM, Gill IS (2008) Halving ischemia time during laparoscopic partial nephrectomy. J Urol 179:627–632PubMedCrossRef
23.
Zurück zum Zitat Ng CK, Gill IS, Patil MB et al (2012) Anatomic renal artery branch microdissection to facilitate zero-ischemia partial nephrectomy. Eur Urol 61(1):67–74PubMedCrossRef Ng CK, Gill IS, Patil MB et al (2012) Anatomic renal artery branch microdissection to facilitate zero-ischemia partial nephrectomy. Eur Urol 61(1):67–74PubMedCrossRef
24.
Zurück zum Zitat Simone G, Papalia R, Guaglianone S et al (2012) ‘Zero ischaemia’, sutureless laparoscopic partial nephrectomy for renal tumours with a low nephrometry score. BJU Int 110(1):124–130PubMedCrossRef Simone G, Papalia R, Guaglianone S et al (2012) ‘Zero ischaemia’, sutureless laparoscopic partial nephrectomy for renal tumours with a low nephrometry score. BJU Int 110(1):124–130PubMedCrossRef
25.
Zurück zum Zitat Minervini A, Siena G (2012) ‘zero ischaemia’, sutureless laparoscopic partial nephrectomy for renal tumours with low nephrometry score. BJU Int 110(1):130 Minervini A, Siena G (2012) ‘zero ischaemia’, sutureless laparoscopic partial nephrectomy for renal tumours with low nephrometry score. BJU Int 110(1):130
26.
Zurück zum Zitat Minervini A, Siena G, Carini M (2013) Hemostatics for nephron-sparing surgery. Expert Rev Med Devices 10(2):153–155PubMedCrossRef Minervini A, Siena G, Carini M (2013) Hemostatics for nephron-sparing surgery. Expert Rev Med Devices 10(2):153–155PubMedCrossRef
27.
Zurück zum Zitat Minervini A, Siena G, Tuccio A et al. (2013) Sutureless Hemostatic Control During Laparoscopic NSS for the Treatment of Small Renal Masses. Surg Innov [Epub ahead of print] Minervini A, Siena G, Tuccio A et al. (2013) Sutureless Hemostatic Control During Laparoscopic NSS for the Treatment of Small Renal Masses. Surg Innov [Epub ahead of print]
28.
Zurück zum Zitat Gill IS (2012) Towards the ideal partial nephrectomy. Eur Urol 62(6):1009–1010 discussion 1011–2PubMedCrossRef Gill IS (2012) Towards the ideal partial nephrectomy. Eur Urol 62(6):1009–1010 discussion 1011–2PubMedCrossRef
29.
Zurück zum Zitat Ficarra V, Novara G, Secco S et al (2009) Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur Urol 56(5):786–793PubMedCrossRef Ficarra V, Novara G, Secco S et al (2009) Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur Urol 56(5):786–793PubMedCrossRef
30.
Zurück zum Zitat Kutikov A, Uzzo RG (2009) The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 182(3):844–853PubMedCrossRef Kutikov A, Uzzo RG (2009) The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 182(3):844–853PubMedCrossRef
Metadaten
Titel
Open versus laparoscopic partial nephrectomy for clinical T1a renal masses: a matched-pair comparison of 280 patients with TRIFECTA outcomes (RECORd Project)
verfasst von
Andrea Minervini
Giampaolo Siena
Alessandro Antonelli
Giampaolo Bianchi
Aldo Massimo Bocciardi
Sergio Cosciani Cunico
Vincenzo Ficarra
Cristian Fiori
Ferdinando Fusco
Andrea Mari
Giuseppe Martorana
Mauro Medica
Vincenzo Mirone
Giuseppe Morgia
Francesco Porpiglia
Francesco Rocco
Bruno Rovereto
Riccardo Schiavina
Claudio Simeone
Carlo Terrone
Alessandro Volpe
Marco Carini
Sergio Serni
and Members of the RECORd Project-LUNA Foundation
Publikationsdatum
01.02.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 1/2014
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-013-1155-7

Weitere Artikel der Ausgabe 1/2014

World Journal of Urology 1/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.